These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19379122)

  • 1. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury.
    Baptiste DC; Tighe A; Fehlings MG
    Expert Opin Investig Drugs; 2009 May; 18(5):663-73. PubMed ID: 19379122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for spinal cord injury.
    Baptiste DC; Fehlings MG
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):63-80. PubMed ID: 18321149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho as a target to promote repair: translation to clinical studies with cethrin.
    McKerracher L; Guertin P
    Curr Pharm Des; 2013; 19(24):4400-10. PubMed ID: 23360272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological approaches to repair the injured spinal cord.
    Baptiste DC; Fehlings MG
    J Neurotrauma; 2006; 23(3-4):318-34. PubMed ID: 16629619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.
    Ahuja CS; Fehlings M
    Stem Cells Transl Med; 2016 Jul; 5(7):914-24. PubMed ID: 27130222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the treatment of spinal cord injury.
    Baptiste DC; Fehlings MG
    Prog Brain Res; 2007; 161():217-33. PubMed ID: 17618980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.
    Fehlings MG; Theodore N; Harrop J; Maurais G; Kuntz C; Shaffrey CI; Kwon BK; Chapman J; Yee A; Tighe A; McKerracher L
    J Neurotrauma; 2011 May; 28(5):787-96. PubMed ID: 21381984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging repair, regeneration, and translational research advances for spinal cord injury.
    Kwon BK; Sekhon LH; Fehlings MG
    Spine (Phila Pa 1976); 2010 Oct; 35(21 Suppl):S263-70. PubMed ID: 20881470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of recruitment and outcomes in the phase I/IIa Cethrin clinical trial for acute spinal cord injury.
    McKerracher L; Anderson KD
    J Neurotrauma; 2013 Nov; 30(21):1795-804. PubMed ID: 23844986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging approaches to the surgical management of acute traumatic spinal cord injury.
    Wilson JR; Fehlings MG
    Neurotherapeutics; 2011 Apr; 8(2):187-94. PubMed ID: 21373951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-surgical management of spinal cord injury.
    Legos JJ; Gopez JJ; Young WF
    Expert Opin Investig Drugs; 2002 Apr; 11(4):469-82. PubMed ID: 11922856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.
    Nagoshi N; Fehlings MG
    Expert Opin Investig Drugs; 2015 May; 24(5):645-58. PubMed ID: 25645889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-ROCK inhibition in the treatment of spinal cord injury.
    Forgione N; Fehlings MG
    World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern Medical Management of Spinal Cord Injury.
    Karsy M; Hawryluk G
    Curr Neurol Neurosci Rep; 2019 Jul; 19(9):65. PubMed ID: 31363857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal Cord Injury and Related Clinical Trials.
    Kim YH; Ha KY; Kim SI
    Clin Orthop Surg; 2017 Mar; 9(1):1-9. PubMed ID: 28261421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial.
    Fehlings MG; Kim KD; Aarabi B; Rizzo M; Bond LM; McKerracher L; Vaccaro AR; Okonkwo DO
    J Neurotrauma; 2018 May; 35(9):1049-1056. PubMed ID: 29316845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Recruitment Feasibility for Acute Spinal Cord Injury Clinical Trials in Canada Using National Registry Data.
    Thibault-Halman G; Rivers CS; Bailey CS; Tsai EC; Drew B; Noonan VK; Fehlings MG; Dvorak MF; Kuerban D; Kwon BK; Christie SD
    J Neurotrauma; 2017 Feb; 34(3):599-606. PubMed ID: 27627704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traumatic Spinal Cord Injury-Repair and Regeneration.
    Ahuja CS; Nori S; Tetreault L; Wilson J; Kwon B; Harrop J; Choi D; Fehlings MG
    Neurosurgery; 2017 Mar; 80(3S):S9-S22. PubMed ID: 28350947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of thyroid hormone enhances oligodendrogenesis and myelination after spinal cord injury.
    Shultz RB; Wang Z; Nong J; Zhang Z; Zhong Y
    J Neural Eng; 2017 Jun; 14(3):036014. PubMed ID: 28358726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord repair in regeneration-competent vertebrates: adult teleost fish as a model system.
    Sîrbulescu RF; Zupanc GK
    Brain Res Rev; 2011 Jun; 67(1-2):73-93. PubMed ID: 21059372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.